{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T14:12:28Z","timestamp":1767276748944},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A cat was presented with mast cell tumors (MCTs) of the skin and spleen. During the initial diagnosis, the exon 8 mutation of <jats:italic>c-KIT<\/jats:italic> was detected in the masses from skin and spleen by a commercial laboratory test. Consequently, treatment with toceranib was started. After complete remission, because of recurrence on day 117, the spleen and skin tumors were removed, but the cat eventually died on day 191. The analysis of ten cDNA clones of the <jats:italic>c-KIT<\/jats:italic> gene cloned from the surgically removed spleen revealed that seven different cDNA patterns were included, indicating the heterogeneity of this gene in the splenic MCT. The seven cDNA nucleotide patterns can be classified into four protein sequence patterns. In addition to the previously known mutations in exon 8, we identified novel mutations in exons 9, 10, and 18; four amino acids deletion in exon 9, and a point mutation in exons 10 and 18. Mouse IL-3-dependent cell line, Ba\/F3, was transduced with these mutant clones, and c-KIT phosphorylation and proliferation assays were performed. We found that certain mutations affected the c-KIT phosphorylation status and cell proliferation. This suggests that heterogeneity among the population of tumor cells exists in MCTs, and that the dominant clones of this heterogeneity may contribute to the subsequent tumor cell growth.<\/jats:p>","DOI":"10.1038\/s41598-022-19089-5","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T09:03:09Z","timestamp":1663837389000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuki","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuha","family":"Shosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"kanako","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako Shimokawa","family":"Miyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Itamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Igase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"19089_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1098612X12470343","volume":"15","author":"C Henry","year":"2013","unstructured":"Henry, C. & Herrera, C. Mast cell tumors in cats: Clinical update and possible new treatment avenues. J. Feline Med. Surg. 15, 41\u201347 (2013).","journal-title":"J. Feline Med. Surg."},{"key":"19089_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2141.2009.07926.x","volume":"148","author":"M Isotani","year":"2010","unstructured":"Isotani, M. et al. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours. Br. J. Haematol. 148, 144\u2013153 (2010).","journal-title":"Br. J. Haematol."},{"key":"19089_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.vetimm.2006.07.004","volume":"114","author":"M Isotani","year":"2006","unstructured":"Isotani, M. et al. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Vet. Immunol. Immunopathol. 114, 168\u2013172 (2006).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"19089_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/vco.12246","volume":"15","author":"S Sabattini","year":"2017","unstructured":"Sabattini, S. et al. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours. Vet. Comp. Oncol. 15, 1051\u20131061 (2017).","journal-title":"Vet. Comp. Oncol."},{"key":"19089_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/1098612X15581205","volume":"18","author":"S Sabattini","year":"2016","unstructured":"Sabattini, S. et al. Feline intestinal mast cell tumours: Clinicopathological characterisation and KIT mutation analysis. J. Feline Med. Surg. 18, 280\u2013289 (2016).","journal-title":"J. Feline Med. Surg."},{"key":"19089_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.tvjl.2014.12.015","volume":"205","author":"M Bonkobara","year":"2015","unstructured":"Bonkobara, M. Dysregulation of tyrosine kinases and use of imatinib in small animal practice. Vet. J. 205, 180\u2013188 (2015).","journal-title":"Vet. J."},{"key":"19089_CR7","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1074\/jbc.M313381200","volume":"279","author":"J Bayle","year":"2004","unstructured":"Bayle, J., Letard, S., Frank, R., Dubreuil, P. & De Sepulveda, P. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J. Biol. Chem. 279, 12249\u201312259 (2004).","journal-title":"J. Biol. Chem."},{"key":"19089_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/00003495-200363050-00005","volume":"63","author":"KF Croom","year":"2003","unstructured":"Croom, K. F. & Perry, C. M. Imatinib mesylate: In the treatment of gastrointestinal stromal tumours. Drugs 63, 513\u2013522 (2003) (discussion 523-4).","journal-title":"Drugs"},{"key":"19089_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/0300985813476064","volume":"50","author":"S Sabattini","year":"2013","unstructured":"Sabattini, S. et al. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors. Vet. Pathol. 50, 797\u2013805 (2013).","journal-title":"Vet. Pathol."},{"key":"19089_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: Past, present, and the future. Cell 168, 613\u2013628 (2017).","journal-title":"Cell"},{"key":"19089_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk, A., Janiszewska, M. & Polyak, K. Intratumor heterogeneity: The Rosetta stone of therapy resistance. Cancer Cell 37, 471\u2013484 (2020).","journal-title":"Cancer Cell"},{"key":"19089_CR12","doi-asserted-by":"publisher","first-page":"30241","DOI":"10.18632\/oncotarget.7148","volume":"7","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Intratumoral KIT mutational heterogeneity and recurrent KIT\/PDGFRA mutations in KIT\/PDGFRA wild-type gastrointestinal stromal tumors. Oncotarget 7, 30241\u201330249 (2016).","journal-title":"Oncotarget"},{"key":"19089_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rvsc.2019.03.003","volume":"124","author":"H Asada","year":"2019","unstructured":"Asada, H. et al. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma. Res. Vet. Sci. 124, 57\u201360 (2019).","journal-title":"Res. Vet. Sci."},{"key":"19089_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jsap.12069","volume":"54","author":"Y Amagai","year":"2013","unstructured":"Amagai, Y. et al. Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours. J. Small Anim. Pract. 54, 377\u2013380 (2013).","journal-title":"J. Small Anim. Pract."},{"key":"19089_CR15","doi-asserted-by":"publisher","first-page":"9159","DOI":"10.1074\/jbc.M211726200","volume":"278","author":"O Voytyuk","year":"2003","unstructured":"Voytyuk, O. et al. Src family kinases are involved in the differential signaling from two splice forms of c-Kit. J. Biol. Chem. 278, 9159\u20139166 (2003).","journal-title":"J. Biol. Chem."},{"key":"19089_CR16","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"BJ Longley Jr","year":"1999","unstructured":"Longley, B. J. Jr. et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc. Natl. Acad. Sci. USA 96, 1609\u20131614 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19089_CR17","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","volume":"103","author":"C Akin","year":"2004","unstructured":"Akin, C. et al. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 103, 3222\u20133225 (2004).","journal-title":"Blood"},{"key":"19089_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/vco.12468","volume":"17","author":"M Igase","year":"2019","unstructured":"Igase, M. et al. Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells. Vet. Comp. Oncol. 17, 184\u2013193 (2019).","journal-title":"Vet. Comp. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19089-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T10:24:57Z","timestamp":1663842297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19089-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15791"}}